Catalyst Wire Dossier Catalyst Wire Dossier

FETZIMA

levomilnacipran hydrochloride · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for FETZIMA, covering 2013-07-25 to 2024-04-19. Get the full timeline:

Most recent: FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)

See pricing